drugset / Trial / NCT05679453

Lornoxicam Versus Etodolac After Third Molar Surgery

NCT05679453

Phase 4 Completed 20 enrolled Kutahya Health Sciences University
RandomizedSequentialDouble-blindPrevention

Summary

Our study aimed to compare the effect of lornoxicam and etodolac on postoperative pain, edema and trismus following lower third molar extraction

Timeline

Start
2022-07-20
Primary completion
2022-09-25
Completion
2022-09-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Etodolac Unknown 400 mg
Comparator Lornoxicam Small molecule 8 mg Oral

Indications

No indication recorded.